Burden of chronic obstructive pulmonary disease and its attributable risk factors in China from 1990 to 2021, with projections to 2050: an analysis of data from the Global Burden of Disease study 2021
Despite substantial reductions in the COPD burden over the past three decades, the disease continues to pose a major health challenge in China, particularly among the aging population. Projections to 2050 indicate continued, though uneven, declines. These findings underscore the urgent need for strengthened diagnostic capacity, risk-targeted prevention efforts, and more effective long-term management strategies tailored to China's aging population.
Authors
- Zhuoyuan Lu
- Xiao Yang (ORCID: https://orcid.org/0000-0003-0437-2015)
- Wanwan Zhang (ORCID: https://orcid.org/0000-0001-7058-9664)
- Lei Zha (ORCID: https://orcid.org/0000-0003-4897-0703)
- Emmanuel Mensah (ORCID: https://orcid.org/0000-0002-4644-8674)
- Shuoshuo Wei
- Yun Zhou (ORCID: https://orcid.org/0000-0001-9011-9459)
- Min Liu (ORCID: https://orcid.org/0000-0002-9007-4817)
Institutions
- Wannan Medical College (CN)
- Bengbu Medical College (CN)
- Wuhu Fourth People Hospital (CN)
- Wuhu No 1 People's Hospital (CN)
- First Affiliated Hospital of Wannan Medical College (CN)
- Lanzhou University (CN)
Publication Details
- Journal
- Frontiers in Medicine
- Published
- 2025-09-03
- DOI
- https://doi.org/10.3389/fmed.2025.1644022
- Citations
- 3
- Primary Topic
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Type
- article
- Field-Weighted Citation Impact
- 4.56
Funders
- Institute for Health Metrics and Evaluation
- Wannan Medical College